Drug intelligence / Profile preview

bone morphogenetic protein-2 + demineralized bone matrix

Development stage
Unknown
Lead developer
Medtronic
Modality
Recombinant Proteins and Enzymes
Administration
Surgical Implantation, Local Application
01

Overview

**Bone morphogenetic protein-2 + demineralized bone matrix** is a combination product used as a bone graft substitute to promote bone regeneration and repair. **Bone morphogenetic protein-2 (BMP-2)** is a recombinant protein that induces osteogenic differentiation, stimulating the formation of new bone tissue. **Demineralized bone matrix (DBM)** is processed allograft bone material from which the mineral content has been removed, retaining organic matrix proteins and endogenous growth factors with osteoinductive and osteoconductive properties. In this combination, DBM serves as a scaffold and carrier for BMP-2, providing a local environment for sustained release and action of BMP-2 at the defect site. This enhances bone healing compared to DBM or BMP-2 alone and mimics the natural bone regeneration process[1][3][4][5]. The combination is used in orthopedic and oral/maxillofacial procedures to treat bone defects and non-unions, and may serve as an alternative to autologous bone grafts[3][4].

Brand names
Infuse Bone Graft
Other names
bone morphogenetic protein-2 plus demineralized bone matrixBMP-2 + DBMBMP-2 with DBMBMP2 with DBMBMP 2 with DBM
02

Targets

BMPR1BBMPR2 (Bone morphogenetic protein receptor type II)BMPR1A

Beyond the preview

Go deeper on bone morphogenetic protein-2 + demineralized bone matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bone morphogenetic protein-2 + demineralized bone matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call